Through our science, our evidence-based actions, our openness, and our respect for those we serve, we will advance cancer-focused research worldwide and reduce the burden of cancer in our catchment area. By engaging with and empowering our exceptionally diverse populations, and addressing their questions and fears, we will engender hope for cancer patients and their families and play a critical role in strengthening the fabric of our communities by gaining and protecting their trust and providing access to the outstanding oncology care each person deserves.

Our mission is to accelerate scientific discovery focused on understanding cancer, innovating cancer treatment, and improving cancer prevention; to provide outstanding, novel, and compassionate patient care; to provide evidence-based and culturally informed education to physicians, nurses, researchers, staff, and the community; and to achieve cancer health equity in our state through outreach to and engagement of our extraordinarily diverse communities.

Curiosity and Discovery, Integrity, Collaboration, Cultivating Diversity, Respect and Caring, Perseverance.

Rutgers, The State University of New Jersey is seeking a Visiting Researcher (PD) within the Rutgers Cancer Institute of New Jersey.

The primary purpose of the Visiting Researcher position is to work under the direction of the principal investigator. The Visiting Researcher will work in the field of Cancer Epigenetics within the Cancer Metabolism and Immunology program. The primary objective of the project is to study the function of key epigenetic regulators that are highly mutated in human cancer, including KDM5C in kidney cancer, ARID2 in melanoma, and/or KDM6A in bladder cancer. These studies will be conducted through the utilization of vertebrate animal models and cultured cell lines. The employee will be responsible for designing, conducting, and analyzing results of molecular cloning, gene expression analyses, cell culture work, tumor xenograft and allograft in mice, and genetically engineered mouse models. The research activities will be conducted primarily in a wet lab setting and will involve various molecular methodologies such as qRT-PCR, FACS, IHC, IF, Western Blotting, Cell Culture, and animal handling.

Among the key duties for this position are the following:

Consistent with the current application of Rutgers Policy 60.3.22, this position may be eligible for a hybrid work arrangement. The flexible work arrangements outlined in Rutgers Policy 60.3.22 are part of a pilot program that is effective September 1, 2022 through August 31, 2024. Therefore, there is no guarantee that this flexible work arrangement will continue beyond that date. Flexible work arrangements are not permanent, are subject to change or cancellation and contingent on the employee receiving approval in the FlexWork@RU Application System. Additional information may be found at https://futureofwork.rutgers.edu.

Rutgers offers a comprehensive benefit program to eligible employees. For details, please go to http://uhr.rutgers.edu/benefits/benefits-overview.